This Edition
ARTICLE | Clinical News
Neuprex opebacan: Phase I/II started
WIR Staff
May 22, 2006 7:00 AM UTC
XOMA started an open-label, investigator-sponsored, U.S. Phase I/II trial in about 6 patients. ...